Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109857 · ClinicalTrials.gov registry record
Bladder Bank (a Prospective Banking Study)
A clinical trial of Bladder Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT06109857 is a study of Bladder Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,500 participants, below the 3,399-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06109857, a study of Bladder Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2022-07-06 |
| Est. Completion | 2027-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06109857
The ClinicalTrials.gov registry entry for NCT06109857 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,399-participant average among 10 other Bladder Carcinoma trials with a reported enrollment target (56% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06109857 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06109857 about?
NCT06109857 is a clinical study titled "Bladder Bank (a Prospective Banking Study)". This study collects blood and urine samples from patients with bladder cancer to support the development of tests for early detection of bladder cancer.
What is the current status of trial NCT06109857?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2022-07-06. Estimated completion is 2027-12-01.
What conditions does trial NCT06109857 study?
This clinical trial studies the following conditions: Bladder Carcinoma.
What interventions are being tested in trial NCT06109857?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06109857?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06109857 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
RECRUITING
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RECRUITING
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.